Off-label use of aducanumab for cerebral amyloid angiopathy

Affiliations

• ¹ Haemorrhagic Stroke Research Program, J Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114 USA. Electronic address: sgreenberg@mgh.harvard.edu.
• ² University of Lille, Inserm, CHU Lille, U1172, LilNCog, Lille Neuroscience and Cognition, F-59000 Lille, France.
• ³ Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
• ⁴ Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
• ⁵ Department of Radiology, Leiden University Medical Center, Leiden, Netherlands.
• ⁶ Haemorrhagic Stroke Research Program, J Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114 USA; Department of Radiology, Leiden University Medical Center, Leiden, Netherlands.
• ⁷ Departments of Neurology and Laboratory Medicine, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Nijmegen, Netherlands.
• ⁸ Haemorrhagic Stroke Research Program, J Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114 USA.
• ⁹ Department of Brain Repair and Rehabilitation, Stroke Research Centre, University College London Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.